US Broker Ratings

HCA Healthcare, Inc. (HCA) Stock Analysis: Exploring 30% Potential Upside with Strong Buy Ratings

HCA Healthcare, Inc. (NYSE: HCA) continues to capture investor attention, backed by its robust operational footprint and compelling growth prospects in the healthcare sector. This Nashville-based giant commands a significant..

Ascendis Pharma A/S (ASND) Stock Analysis: A Biotech Powerhouse with 36.97% Potential Upside

In the competitive world of biotechnology, Ascendis Pharma A/S (NASDAQ: ASND) stands out as a compelling investment opportunity. With its innovative approach to addressing unmet medical needs, the Denmark-based biopharmaceutical..

Exelixis, Inc. (EXEL) Stock Analysis: Exploring Growth Potential in Oncology Biotechnology

Exelixis, Inc. (NASDAQ: EXEL) stands out in the biotechnology sector, specializing in developing therapies for hard-to-treat cancers. With a market capitalization of $13.35 billion, the company is a significant player..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating a 39% Potential Upside Amidst Cutting-Edge Healthcare Innovations

In the ever-evolving landscape of healthcare technology, Tempus AI, Inc. (NASDAQ: TEM) has emerged as a prominent contender, leveraging its innovative platform to revolutionize health information services. As a company..

ICON plc (ICLR) Stock Analysis: Navigating Growth with Strategic Clinical Innovations

ICON plc (NASDAQ: ICLR) stands as a pivotal player in the healthcare sector, particularly within the Diagnostics & Research industry. With its headquarters in Dublin, Ireland, this clinical research organization..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 21.85% Upside Potential

United Therapeutics Corporation (NASDAQ: UTHR) has captured investor attention with its robust pipeline of innovative treatments for chronic and life-threatening diseases, coupled with a promising upside potential of 21.85%. Trading..

McKesson Corporation (MCK) Stock Analysis: A Strong Buy with 20% Upside Potential

McKesson Corporation (NYSE: MCK), a titan in the healthcare sector, stands out as a compelling investment opportunity with a potential upside of 20.07% based on current analyst ratings. This medical..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring a 37% Upside Potential and Robust Revenue Growth

Intuitive Surgical, Inc. (NASDAQ: ISRG), a pioneering force in the healthcare sector, continues to captivate investor interest with its advanced medical instruments and supplies, specifically its renowned da Vinci Surgical..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Investor Outlook Highlights 20.73% Potential Upside

Neurocrine Biosciences, Inc. (NBIX), a prominent player in the healthcare sector, is making waves with its robust pipeline of pharmaceuticals focused on neurological and psychiatric disorders. With a market capitalization..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Exploring a 27.67% Potential Upside

Thermo Fisher Scientific Inc (NYSE: TMO), a titan in the healthcare sector, particularly in diagnostics and research, stands as a compelling investment opportunity for those seeking exposure to the life..

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a 19.58% Upside Potential

Align Technology, Inc. (NASDAQ: ALGN), a key player in the healthcare sector under the medical instruments and supplies industry, is renowned for its innovative Invisalign clear aligners and iTero intraoral..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Valuation Insights and Growth Potential

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the healthcare sector, stands as a formidable entity within the drug manufacturing industry, particularly in the specialty and generic categories...

Elevance Health, Inc. (ELV) Stock Analysis: Navigating the Healthcare Giant’s Growth Potential

Elevance Health, Inc. (NYSE: ELV), formerly known as Anthem, Inc., is a pivotal player in the healthcare plans industry in the United States, with a substantial market capitalization of $87.75..

Haleon plc (HLN) Stock Analysis: Exploring a 28.59% Potential Upside in the Healthcare Sector

Haleon plc (NYSE: HLN), a prominent player in the healthcare sector, has been capturing investor attention with its robust market presence and significant potential upside. Specializing in consumer healthcare products,..

AptarGroup, Inc. (ATR) Stock Analysis: Evaluating a 36% Potential Upside in Medical Instruments

AptarGroup, Inc. (NYSE: ATR), a key player in the medical instruments and supplies industry, is capturing investor attention with its promising 36.28% potential upside. With a strong foothold in the..

Waters Corporation (WAT) Investor Outlook: Analyzing a 12.58% Potential Upside

Waters Corporation (NYSE: WAT), a prominent player in the healthcare sector, stands at a compelling juncture for investors seeking opportunities in the diagnostics and research industry. With a significant market..

Becton, Dickinson and Company (BDX): Investor Outlook with a 23.56% Potential Upside

As individual investors seek promising opportunities within the healthcare sector, Becton, Dickinson and Company (NYSE: BDX) stands out with a compelling narrative driven by its substantive market presence and potential..

Illumina, Inc. (ILMN): Investor Outlook on a Genomic Pioneer with a 33.82% ROE

Illumina, Inc. (NASDAQ: ILMN) stands as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Known for its sequencing and array-based solutions, Illumina provides essential..

Cencora, Inc. (COR) Stock Analysis: Exploring a 24% Potential Upside in Healthcare Distribution

Cencora, Inc. (NYSE: COR), a prominent player in the healthcare distribution industry, stands out with a compelling market cap of $54.8 billion. The company, formerly known as AmerisourceBergen Corporation, has..

Regeneron Pharmaceuticals, Inc. (REGN)

⚠️ No article content returned.

..
Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds